The effervescent tablet market size has grown strongly in recent years. It will grow from $36.41 billion in 2024 to $39.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to early pharmaceutical innovations, medical advancements, emergence of consumer health trends, consumer convenience and preference, marketing and branding strategies.
The effervescent tablet market size is expected to see rapid growth in the next few years. It will grow to $60.99 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to preference for convenient dosage forms, innovation in formulations, consumer demand for novelty, healthcare professional endorsements, demographic shifts. Major trends in the forecast period include market value structure, cost drivers, growth rate, sales channels, and technological advancements.
The high prevalence of chronic diseases is anticipated to drive the growth of the effervescent tablets market in the coming years. Chronic diseases typically last for three months or longer and may worsen over time. Some of the most common chronic diseases include cancer, heart disease, stroke, diabetes, and arthritis. Effervescent tablets are utilized in treating chronic illnesses like diabetes, cancer, and heart disease due to their potent antioxidant properties, which help increase blood antioxidant levels and reduce the risk of chronic diseases. For example, in January 2022, research published by the American Cancer Society, a U.S.-based health organization, projected that there would be 609,360 cancer deaths and 1.9 million new cancer cases in the U.S. in 2022, translating to about 1,670 fatalities each day. Thus, the high prevalence of chronic diseases is fueling the growth of the effervescent tablets market.
The growing geriatric population is expected to enhance the growth of the effervescent tablet market moving forward. The geriatric population refers to individuals aged 65 and older in relation to those between 18 and 64 who are employed. The rise in the elderly population presents a significant market opportunity for effervescent tablets, which cater to the unique healthcare needs and preferences of this demographic through formulation advantages, user-friendly administration, and customization options that make them an appealing choice for effective and convenient healthcare solutions. For instance, in October 2022, a report from the World Health Organization (WHO), a Switzerland-based agency focused on international public health, indicated that one in six people is projected to be 60 or older by 2030 globally. By 2050, the global population of individuals aged 60 years and older is expected to reach 2.1 billion, with the number of people aged 80 and older increasing by 426 million between 2020 and 2050 compared to current figures. Therefore, the rise in the geriatric population is contributing to the growth of the effervescent tablet market.
Technological advancements are a significant trend gaining traction in the effervescent tablet market. Key players are focusing on developing innovative manufacturing technologies to maintain their competitive edge. For example, in April 2022, Health Innovations Ltd., a UK-based company specializing in healthcare supplements, introduced EfferShield technology. EfferShield is a patented technology designed for effervescent tablets and powders, offered in single-use pouches and stick-pack packaging. This provides consumers with more flexible and convenient packaging options that also include possibilities for recycling and at-home composting.
Leading companies in the effervescent tablet market are prioritizing the development of advancements such as Liposomal Glutathione Effervescent Tablets to enhance bioavailability, improve antioxidant delivery, and meet the increasing consumer demand for convenient and effective health supplements. These Liposomal Glutathione Effervescent Tablets merge advanced absorption technology with antioxidant benefits, providing a practical and effective means to support immune function, detoxification, and overall health. For instance, in August 2024, INJA Wellness, a U.S.-based company focused on wellness products, including health-promoting supplements, launched Liposomal Glutathione Effervescent Tablets. These tablets utilize advanced liposomal technology to boost the absorption of glutathione, a potent antioxidant, and are designed to dissolve in water for easy consumption, thereby supporting immune health.
In February 2024, EffRx Pharmaceuticals SA, a Switzerland-based pharmaceutical company that includes effervescent tablets, announced a partnership with Lupin Limited. This collaboration aims to commercialize BINOSTO (alendronate 70 mg effervescent tablets) in Vietnam and the Philippines, primarily for treating postmenopausal osteoporosis in women. Lupin Limited is an India-based pharmaceutical company.
Major companies operating in the effervescent tablet market are Bayer AG, Hermes Arzneimittel GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Bristol-Myers Squibb Company, Bliss GVS Pharma Limited, Herbalife International Inc., Amerilab Technologies Inc., Pfizer Inc., Novartis AG, Perrigo Company PLC, Chiesi Farmaceutici SpA, SG Biopharm Pvt. Ltd., Tower Laboratories Ltd., American Health, By-health Co. Ltd., Vitabiotics Ltd., Prestige Brands Inc., Nuun and Company Inc., Amway Corp, GNC Holdings Inc., Sanofi SA, Merck KGaA, Roche Holding AG, Johnson & Johnson, Nestle SA, Dr Reddy's Laboratories Ltd.
North America was the largest region in the effervescent tablets market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the effervescent tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the effervescent tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Effervescent tablets are a solid dosage form designed to dissolve rapidly when in contact with water, releasing carbon dioxide. This rapid disintegration allows the tablets to dissolve completely within minutes, releasing the contained medication or supplement into solution.
The main categories of effervescent tablets include medication and supplements. Medications encompass drugs and medical preparations used to treat various biological abnormalities and illnesses. The preparation methods for effervescent tablets include dry methods and wet granulation. These tablets are utilized for a range of indications, including diuretics, pain management, gastric disorders, respiratory diseases, and more. They find applications in dental products, dietary supplements, pharmaceuticals, and other areas. Effervescent tablets are used by various end-users such as hospitals, specialty clinics, home care, and others.
The effervescent tablets market research report is one of a series of new reports that provides effervescent tablets market statistics, including effervescent tablets industry global market size, regional shares, competitors with an effervescent tablets market share, detailed effervescent tablets market segments, market trends and opportunities, and any further data you may need to thrive in the effervescent tablets industry. This effervescent tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The effervescent tablet market consists of sales of prescription-based tablets and daily-used tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The effervescent tablet market size is expected to see rapid growth in the next few years. It will grow to $60.99 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to preference for convenient dosage forms, innovation in formulations, consumer demand for novelty, healthcare professional endorsements, demographic shifts. Major trends in the forecast period include market value structure, cost drivers, growth rate, sales channels, and technological advancements.
The high prevalence of chronic diseases is anticipated to drive the growth of the effervescent tablets market in the coming years. Chronic diseases typically last for three months or longer and may worsen over time. Some of the most common chronic diseases include cancer, heart disease, stroke, diabetes, and arthritis. Effervescent tablets are utilized in treating chronic illnesses like diabetes, cancer, and heart disease due to their potent antioxidant properties, which help increase blood antioxidant levels and reduce the risk of chronic diseases. For example, in January 2022, research published by the American Cancer Society, a U.S.-based health organization, projected that there would be 609,360 cancer deaths and 1.9 million new cancer cases in the U.S. in 2022, translating to about 1,670 fatalities each day. Thus, the high prevalence of chronic diseases is fueling the growth of the effervescent tablets market.
The growing geriatric population is expected to enhance the growth of the effervescent tablet market moving forward. The geriatric population refers to individuals aged 65 and older in relation to those between 18 and 64 who are employed. The rise in the elderly population presents a significant market opportunity for effervescent tablets, which cater to the unique healthcare needs and preferences of this demographic through formulation advantages, user-friendly administration, and customization options that make them an appealing choice for effective and convenient healthcare solutions. For instance, in October 2022, a report from the World Health Organization (WHO), a Switzerland-based agency focused on international public health, indicated that one in six people is projected to be 60 or older by 2030 globally. By 2050, the global population of individuals aged 60 years and older is expected to reach 2.1 billion, with the number of people aged 80 and older increasing by 426 million between 2020 and 2050 compared to current figures. Therefore, the rise in the geriatric population is contributing to the growth of the effervescent tablet market.
Technological advancements are a significant trend gaining traction in the effervescent tablet market. Key players are focusing on developing innovative manufacturing technologies to maintain their competitive edge. For example, in April 2022, Health Innovations Ltd., a UK-based company specializing in healthcare supplements, introduced EfferShield technology. EfferShield is a patented technology designed for effervescent tablets and powders, offered in single-use pouches and stick-pack packaging. This provides consumers with more flexible and convenient packaging options that also include possibilities for recycling and at-home composting.
Leading companies in the effervescent tablet market are prioritizing the development of advancements such as Liposomal Glutathione Effervescent Tablets to enhance bioavailability, improve antioxidant delivery, and meet the increasing consumer demand for convenient and effective health supplements. These Liposomal Glutathione Effervescent Tablets merge advanced absorption technology with antioxidant benefits, providing a practical and effective means to support immune function, detoxification, and overall health. For instance, in August 2024, INJA Wellness, a U.S.-based company focused on wellness products, including health-promoting supplements, launched Liposomal Glutathione Effervescent Tablets. These tablets utilize advanced liposomal technology to boost the absorption of glutathione, a potent antioxidant, and are designed to dissolve in water for easy consumption, thereby supporting immune health.
In February 2024, EffRx Pharmaceuticals SA, a Switzerland-based pharmaceutical company that includes effervescent tablets, announced a partnership with Lupin Limited. This collaboration aims to commercialize BINOSTO (alendronate 70 mg effervescent tablets) in Vietnam and the Philippines, primarily for treating postmenopausal osteoporosis in women. Lupin Limited is an India-based pharmaceutical company.
Major companies operating in the effervescent tablet market are Bayer AG, Hermes Arzneimittel GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Bristol-Myers Squibb Company, Bliss GVS Pharma Limited, Herbalife International Inc., Amerilab Technologies Inc., Pfizer Inc., Novartis AG, Perrigo Company PLC, Chiesi Farmaceutici SpA, SG Biopharm Pvt. Ltd., Tower Laboratories Ltd., American Health, By-health Co. Ltd., Vitabiotics Ltd., Prestige Brands Inc., Nuun and Company Inc., Amway Corp, GNC Holdings Inc., Sanofi SA, Merck KGaA, Roche Holding AG, Johnson & Johnson, Nestle SA, Dr Reddy's Laboratories Ltd.
North America was the largest region in the effervescent tablets market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the effervescent tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the effervescent tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Effervescent tablets are a solid dosage form designed to dissolve rapidly when in contact with water, releasing carbon dioxide. This rapid disintegration allows the tablets to dissolve completely within minutes, releasing the contained medication or supplement into solution.
The main categories of effervescent tablets include medication and supplements. Medications encompass drugs and medical preparations used to treat various biological abnormalities and illnesses. The preparation methods for effervescent tablets include dry methods and wet granulation. These tablets are utilized for a range of indications, including diuretics, pain management, gastric disorders, respiratory diseases, and more. They find applications in dental products, dietary supplements, pharmaceuticals, and other areas. Effervescent tablets are used by various end-users such as hospitals, specialty clinics, home care, and others.
The effervescent tablets market research report is one of a series of new reports that provides effervescent tablets market statistics, including effervescent tablets industry global market size, regional shares, competitors with an effervescent tablets market share, detailed effervescent tablets market segments, market trends and opportunities, and any further data you may need to thrive in the effervescent tablets industry. This effervescent tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The effervescent tablet market consists of sales of prescription-based tablets and daily-used tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Effervescent Tablet Market Characteristics3. Effervescent Tablet Market Trends and Strategies4. Effervescent Tablet Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Effervescent Tablet Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Effervescent Tablet Market34. Recent Developments in the Effervescent Tablet Market
5. Global Effervescent Tablet Growth Analysis and Strategic Analysis Framework
6. Effervescent Tablet Market Segmentation
7. Effervescent Tablet Market Regional and Country Analysis
8. Asia-Pacific Effervescent Tablet Market
9. China Effervescent Tablet Market
10. India Effervescent Tablet Market
11. Japan Effervescent Tablet Market
12. Australia Effervescent Tablet Market
13. Indonesia Effervescent Tablet Market
14. South Korea Effervescent Tablet Market
15. Western Europe Effervescent Tablet Market
16. UK Effervescent Tablet Market
17. Germany Effervescent Tablet Market
18. France Effervescent Tablet Market
19. Italy Effervescent Tablet Market
20. Spain Effervescent Tablet Market
21. Eastern Europe Effervescent Tablet Market
22. Russia Effervescent Tablet Market
23. North America Effervescent Tablet Market
24. USA Effervescent Tablet Market
25. Canada Effervescent Tablet Market
26. South America Effervescent Tablet Market
27. Brazil Effervescent Tablet Market
28. Middle East Effervescent Tablet Market
29. Africa Effervescent Tablet Market
30. Effervescent Tablet Market Competitive Landscape and Company Profiles
31. Effervescent Tablet Market Other Major and Innovative Companies
35. Effervescent Tablet Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Effervescent Tablet Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on effervescent tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for effervescent tablet? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The effervescent tablet market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product: Medication; Supplements2) by Methods: Dry Methods; Wet Granulation
3) by Indication: Diuretics; Pain Management; Gastric Disorders; Respiratory Diseases; Other Indications
4) by Application: Dental Products; Dietary Supplements; Pharmaceutical; Other Applications
5) by End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) by Medication: Pain Relief Tablets; Cold and Flu Remedies; Digestive Health Tablets; Antacids2) by Supplements: Vitamin and Mineral Supplements; Electrolyte Supplements; Herbal Supplements; Energy and Sports Supplements
Key Companies Mentioned: Bayer AG; Hermes Arzneimittel GmbH; GlaxoSmithKline PLC; Reckitt Benckiser Group PLC; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Effervescent Tablet market report include:- Bayer AG
- Hermes Arzneimittel GmbH
- GlaxoSmithKline PLC
- Reckitt Benckiser Group PLC
- Bristol-Myers Squibb Company
- Bliss GVS Pharma Limited
- Herbalife International Inc.
- Amerilab Technologies Inc.
- Pfizer Inc.
- Novartis AG
- Perrigo Company PLC
- Chiesi Farmaceutici SpA
- SG Biopharm Pvt. Ltd.
- Tower Laboratories Ltd.
- American Health
- By-health Co. Ltd.
- Vitabiotics Ltd.
- Prestige Brands Inc.
- Nuun and Company Inc.
- Amway Corp
- GNC Holdings Inc.
- Sanofi SA
- Merck KGaA
- Roche Holding AG
- Johnson & Johnson
- Nestle SA
- Dr Reddy's Laboratories Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 39.97 Billion |
| Forecasted Market Value ( USD | $ 60.99 Billion |
| Compound Annual Growth Rate | 11.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
